
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
FLAMSA-MEL regimen
Introduction
Synonyms and keywords:
Overview
Overview
FLAMSA-MEL regimen refers to a regimen consisting of fludarabine, amsacrine, cytarabine (Ara-C) and melphalan used to upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia.[1]
Regimen
Regimen
FLFludarabine
AMSAmsacrine
ACytarabine (Ara-C)
MELMelphalan
References
References
- ↑ 1.0 1.1 Saure C, Schroeder T, Zohren F, Groten A, Bruns I, Czibere A; et al. (2012). “Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen”. Biol Blood Marrow Transplant. 18 (3): 466–72. doi:10.1016/j.bbmt.2011.09.006. PMID 21963618.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
